logo
Share SHARE
FONT-SIZE Plus   Neg

Catalyst Pharmaceutical Partners Raises $6 Mln In Registered Direct Offering

Catalyst Pharmaceutical Partners Inc. (CPRX) has reached definitive agreements to sell 4.0 million common shares, and common stock purchase warrants to buy an aggregate of 1.2 million shares, in a registered direct public offering. The aggregate offering price for each share and corresponding warrant is $1.50, resulting in gross proceeds of $6 million.

The common stock purchase warrants have a five year-term and an exercise price of $2.08 per share. The offering may close on or about August 31, 2012. Catalyst expects to use the net proceeds from this offering to fund costs associated with the company's product development efforts and for general corporate purposes. Roth Capital Partners has acted as the exclusive placement agent for the transaction.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Takata Corp. will file for bankruptcy protection on Monday as the Japanese airbag maker seeks protection from creditors following billions of dollars in liabilities linked to a massive global recall of defective air bags, Reuters reported Thursday, citing two sources. Troubled mortgage lender Home Capital Group Inc. (HCG.TO) is hoping for a new lease of life with Warren buffet extending a helping hand by way of C$2 billion or $1.5 billion line of credit to its subsidiary Home Trust Co. The credit from the renowned investor will help end the strategic review of the lender and to settle a loan facility from an institutional investor. Cable company Altice USA Inc. increased Wednesday the number of shares it will sell in its initial public offering by 37%, raising around $1.9 billion. In the IPO, the company offered 63.94 million shares at a price of $30 per share, higher than the 46.6 million shares announced last month.
comments powered by Disqus
Follow RTT